This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
US releases 2025 Notorious Markets report, EFF files brief in DMCA subpoena case and House of the Dragon tops piracy lists. The post 3 Count: Notorious Markets 2025 appeared first on Plagiarism Today.
This latest edition features an interview with retiring longtime Wilson Sonsini IP partner Vern Norviel and articles on MedTech and pharma trends for 2025, the eligibility of life sciences companies for qualified small business stock, what life sciences companies need to know about brands, double-patenting jeopardy, and life sciences venture financings for clients across 2H 2023 and 1H 2024.
The First Lady of South Korea is facing allegations of plagiarism in her thesis. This news comes at a very bad time for her and her husband. The post South Korean First Lady Accused of Plagiarizing Thesis appeared first on Plagiarism Today.
Also looking for an "opportunity". A new year has just begun and, as expected, new IP adventures and opportunities are on the horizon as well! Take a look below and, as always, do not forget to check our Events page on a regular basis. Katcall The IPKat is seeking to "recruit" new GuestKats and InternKats. If that sounds like your (Kat)calling, do not forget to apply by 20 January 2025.
Software is complex, which makes threats to the software supply chain more real every day. 64% of organizations have been impacted by a software supply chain attack and 60% of data breaches are due to unpatched software vulnerabilities. In the U.S. alone, cyber losses totaled $10.3 billion in 2022. All of these stats beg the question, “Do you know what’s in your software?
Due diligence is a necessary part of any M&A transaction. This process can be an exhaustive deep dive into the target companys history. In some cases, the buyer wants to assure itself of certain highly confidential and sensitive aspects of the targets operations and assets. We most commonly see this arise in relation to proprietary software and source code, customer lists, executive compensation, and the risks become most acute where the buyer and target are competitors.
Building a brand is no small task. But once youve invested time and effort into your unique name, logo, or slogan, protecting it is essential. While many businesses go through the process of trademark registration , not every brand needs to take that route right away. Enter common law trademarks a practical way to secure certain rights to your brand from the moment you start using it, without the registration process or fees.
For branded drugmakers, the development of a pharmaceutical product approved by the Food and Drug Administration (FDA) all but assures generic competition. As discussed during the first installment of our Hatch-Waxman series, Hatch-Waxman 101, disputes between branded and generic drugmakers are governed by the Hatch-Waxman Act, which attempts to strike a balance between the pharmaceutical industry's need to protect its innovations and the public's need for affordable drugs.
For branded drugmakers, the development of a pharmaceutical product approved by the Food and Drug Administration (FDA) all but assures generic competition. As discussed during the first installment of our Hatch-Waxman series, Hatch-Waxman 101, disputes between branded and generic drugmakers are governed by the Hatch-Waxman Act, which attempts to strike a balance between the pharmaceutical industry's need to protect its innovations and the public's need for affordable drugs.
Pramudji Law Group PLLC, a Houston-based IP boutique law firm, is seeking a patent agent/patent attorney/patent engineer with a degree in Electrical Engineering, Computer Engineering, or Physics. This position entails drafting and prosecuting patent applications and performing invalidity and infringement analysis. We are looking for candidates who have a strong technical background, particularly in microprocessor technology, computer memory architecture, or integrated circuit design.
OpenAI and its backers at Microsoft will try persuading a New York judge to dismiss one of the major copyright suits against them, with arguments that using news stories to train the startup's artificial intelligence model is a "transformative" use.Here's a spotlight on where that case stands plus all the other major intellectual property matters on deck in the coming week.
The proliferation of generative artificial intelligence (GAI) models over the past few years has given rise to well over thirty copyright infringement lawsuits by copyright owners against GAI developers. While […] The post AI Lawsuit Developments in 2024: A Year in Review appeared first on Copyright Alliance.
As an investor, you know that a startups intellectual property (IP) can be among its most valuable assets. A strong IP portfolio not only helps secure a companys unique market position but also reduces competitive threats and enhances investment returns.
Women and diverse employees have the technical skill and knowledge, yet their contributions are not patented at the same rate as those of their male counterparts.This toolkit can help organizations move the needle on achieving gender parity in innovation.
Introduction Trademarks are valuable assets for businesses; they reflect the identity, reputation and goodwill that a company builds with its target consumer. They can include anything from a company’s name and logo to slogans, product packaging or even distinct sounds or colors. However, filing for a trademark is one thing; maintaining its continued existence is equally essential.
As the new year begins, prudent service providers will review and consider updating their contract forms to ensure they align with the company's strategic goals and comply with any current or upcoming laws and regulations. To help with this process, service providers should contemplate the following list of considerations when updating or drafting service contracts in 2025.
Florida-based Catalyst Pharmaceuticals Inc. has reached a settlement with Teva in a patent infringement battle in New Jersey federal court over its U.S. flagship commercial drug that treats a rare autoimmune disease that will provide Teva with a license to market a generic version of the drug in 2035, the company announced Thursday.
If you are concerned your companys innovations are not being identified and evaluated for possible patent protection, resolve to implement or improve an invention capture process early in 2025. By efficiently identifying valuable inventions and taking steps to pursue patents, your company can gain a competitive edge.
A Georgia federal judge said Thursday that the Glioblastoma Foundation Inc. can't yet escape a series of counterclaims filed against it by a rival nonprofit amid a trademark spat, ruling that its defenses in a dismissal bid largely relied on factual issues about whether the rival fraudulently obtained the marks at issue.
A California federal judge appeared open Thursday to allowing authors to amend their copyright infringement proposed class action to include allegations Meta nefariously removed copyright disclaimers from tens of millions of books in creating its Llama artificial intelligence product, while criticizing Meta's "grossly overbroad" sealing requests as illegitimate attempts at avoiding bad publicity.
Brands are taking over the produce aisle at the grocery store. They have already conquered the cereal aisle, the soda aisle, the chips aisle, and the cookie aisle (my favorite). While there have always been produce brands (Chiquita bananas or Dole pineapple), branded fruits and vegetables are proliferating.
Policy outfit US Inventor Inc. has spoken out against the return of Rep. Darrell Issa, R-Calif., to head the U.S. House subcommittee overseeing intellectual property in the new Congress, warning on Thursday Issa's leadership role will have distressing affects on American startups and innovators while benefiting foreign competitors in other countries like China.
In addition to Continuation and Information Disclosure Statement (IDS) fee changes, the United States Patent & Trademark Offices (USPTO) published final rule also increases front-end filing fees. By: Sterne, Kessler, Goldstein & Fox P.L.L.C.
Amgen has asked a Virginia federal judge to permanently toss the latest version of a proposed class action accusing it of illegally entrenching and expanding patent rights to stave off cheaper competition for Enbrel, arguing the blockbuster arthritis treatment is protected by legitimate patents and court rulings of validity.
Honeywell International Inc., et al. v. 3G Licensing, S.A., Nos. 2023-1354, -1384, -1407 (Fed. Cir. (PTAB) Jan. 2, 2025). Opinion by Dyk, joined by Chen. Dissenting opinion by Stoll.
A vape-maker has urged a California federal court to deny a bid by the founder of vape distributor Next Level to arbitrate the manufacturer's claims that he broke into a laptop to access its confidential information, saying he's not a signatory to an underlying arbitration agreement.
When issued patent drawings are not explicitly made to scale, the Federal Circuit recently confirmed that arguments relying solely or predominately on the features of those drawings, such as line thickness, are unavailing. The Regents of the University of California v. Satco Products, Inc., Appeal No. 2023-1356 (Fed. Cir. Dec. 4, 2024). In Regents, the court vacated-in-part a PTAB Final Written Decision invalidating a claim based on the thickness of a line in the prior-art patent figures and.
A U.S. International Trade Commission judge has shot down Amazon's arguments that Nokia failed to offer reasonable or nondiscriminatory patent license terms, ruling instead that Amazon was infringing a series of Nokia patents related to video technology.
A Maryland federal judge has determined chemical company W.R. Grace made false statements when publicly comparing its product to competitor G.W. Aru, but left most questions of injury, invalidity and additional infringement for a May trial.
The International Trademark Association (INTA) announced today that it has filed an amicus brief in a referral to the Grand Board of Appeal of the European Union Intellectual Property Office (EUIPO) that asks for clarification on registering human faces as trademarks. INTA urged the Grand Board to confirm that signs consisting of photorealistic facial images of people, including famous ones, are not per se excluded from trademark protection.
Attorneys at Rothwell Figg provide highlights on procedural and substantive intellectual property issues pertaining to AI in 2024 from the Copyright Office and U.S. Patent and Trademark Office, followed by what to expect in 2025.
In a recent chapter, Ryan Abbott and Elizabeth Rothman present the utilitarian argument for granting copyright in AI-generated works (hereafter AIGW). Aspects of their argument also find expression in the recently launched UK Intellectual Property Office (UKIPO) consultation on AI. In response, this post outlines my scepticism. The utilitarian arguments supporting copyright in AIGW are empirically speculative and theoretically dubious.
A California federal judge has tacked on about $237 million in interest to the $316 million damages verdict SPEX Technologies won after a jury found Western Digital infringed a patent related to hardware encryption technology.
The Ninth and Second Circuit Courts of Appeal recently issued decisions confirming that competitive keyword advertising does not create a likelihood of confusion where the plaintiffs trademark does not appear in the resulting advertising copy or otherwise cause meaningful consumer confusion. The decisions validate the long-standing practice of competitive keyword advertising and demonstrate a growing consensus that the mere act of purchasing a competitors trademarks does not constitute.
A former junior-college basketball player seeking to play one more season is not entitled to do so because he has played the maximum number of seasons allowed, the NCAA told a Mississippi federal court in defense of the eligibility policy the player seeks to upend.
Reading Time: 3 minutes Move over shady NYC alleysWalmart has entered the chat, serving up knockoff dreams faster than a blue-vested employee can say Rollback. Yes, the same retail wonderland where, in a single shopping trip, you can snag a family-sized bag of Oreos for questionable dinner choices, a bulk pack of socks destined to vanish into the void, a lawnmower that might moonlight as a leaf blower, and a vacuum so powerful it sucks up your will to do anything else for the rest of the weekend
The owner of a whiskey company accused of ripping off the name used by a host of hospitality brands owned by Houston billionaire Tilman Fertitta testified that he started his company with the honest belief that the name "Landry" was available for use for liquor sales.
We organize all of the trending information in your field so you don't have to. Join 9,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content